Short term comparative study of topical 2% carteolol with and without benzalkonium chloride in healthy volunteers

被引:121
作者
Baudouin, C
de Lunardo, C
机构
[1] Univ Paris 05, Ambroise Pare, Dept Ophthalmol, F-75270 Paris 06, France
[2] Univ Nice, Pasteur Hosp, Ctr Clin Pharmacol, F-06108 Nice, France
关键词
D O I
10.1136/bjo.82.1.39
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Aim-A crossover, randomised double blind study was undertaken in 30 healthy volunteers, in order to compare the tolerance of 2% carteolol with and without preservative in short term use. Methods-Complete ophthalmic examinations were performed before and 30, 60, and 180 minutes after instillation of one drop of the solution, and after 3 days of preservative treatment. After a 5 day washout, the same examinations were done with the second drug. Results-Results showed good general tolerance for both formulations. No significant difference in subjective tolerance, corneal aesthesiometry, punctuate keratitis, Schirmer's test, intraocular pressure (IOP) decrease (about 25% in the two groups at 3 hours, 10% after 3 days of treatment), resting cardiac frequency, or blood pressure was observed. However, break up time was I;significantly reduced from baseline by preserved carteolol both at 3 hours (10.40 (5.9) seconds to 6.15 (3.9:) seconds, p=0.001) and after 3 days (7.72 (5.5) seconds, p=0.04). Preservative free carteolol did not significantly change the break up time (baseline 9.08 (5.7) seconds; 3 hours = 7.88 (5.5) seconds, not significant; day 3 = 8.35 (5.8), non-significant). Conclusions-These results confirm that carteolol is well tolerated, either with or without preservative. The preservative free group showed better stability of the tear film, without Ic,ss of effect This difference, although healthy young subjects in the present study could be much more relevant ill those patients treated long term, older patients, and/or those suffering from ocular surface disorders. In such instances, preservative free drugs could be of potential benefit to protect the lacrimal fluid integrity and corneoconjunctival surface.
引用
收藏
页码:39 / 42
页数:4
相关论文
共 21 条
[1]   DRUG-INDUCED OCULAR PSEUDOPEMPHIGOID [J].
ANDERS, N ;
WOLLENSAK, J .
KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 1994, 205 (02) :61-64
[2]  
BAUDOUIN C, 1994, OPHTHALMOLOGY, V101, P454
[3]   A SINGLE DOSE OF 3 DIFFERENT OPHTHALMIC BETA-BLOCKERS ANTAGONIZES THE CHRONOTROPIC EFFECT OF ISOPROTERENOL IN HEALTHY-VOLUNTEERS [J].
BERLIN, I ;
MARCEL, P ;
UZZAN, B ;
MILLON, D ;
LEHOANG, P ;
PUECH, AJ .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1987, 41 (06) :622-626
[4]   CONJUNCTIVAL IMPRESSION CYTOLOGY IN PATIENTS WITH GLAUCOMA USING LONG-TERM TOPICAL MEDICATION [J].
BRANDT, JD ;
WITTPENN, JR ;
KATZ, LJ ;
STEINMANN, WN ;
SPAETH, GL .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1991, 112 (03) :297-301
[5]   ADVERSE-EFFECTS OF TOPICAL ANTIGLAUCOMA MEDICATION .2. THE OUTCOME OF FILTRATION SURGERY [J].
BROADWAY, DC ;
GRIERSON, I ;
OBRIEN, C ;
HITCHINGS, RA .
ARCHIVES OF OPHTHALMOLOGY, 1994, 112 (11) :1446-1454
[6]   ADVERSE-EFFECTS OF TOPICAL ANTIGLAUCOMA MEDICATION .1. THE CONJUNCTIVAL CELL PROFILE [J].
BROADWAY, DC ;
GRIERSON, I ;
OBRIEN, C ;
HITCHINGS, RA .
ARCHIVES OF OPHTHALMOLOGY, 1994, 112 (11) :1437-1445
[7]  
BURSTEIN NL, 1980, INVEST OPHTH VIS SCI, V19, P308
[8]   OCULAR CARTEOLOL - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES, AND THERAPEUTIC USE IN GLAUCOMA AND OCULAR HYPERTENSION [J].
CHRISP, P ;
SORKIN, EM .
DRUGS & AGING, 1992, 2 (01) :58-77
[9]   TOPICAL TIMOLOL WITH AND WITHOUT BENZALKONIUM CHLORIDE - EPITHELIAL PERMEABILITY AND AUTOFLUORESCENCE OF THE CORNEA IN GLAUCOMA [J].
DEJONG, C ;
STOLWIJK, T ;
KUPPENS, E ;
DEKEIZER, R ;
VANBEST, J .
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 1994, 232 (04) :221-224
[10]  
DENIS P, 1993, J FR OPHTALMOL, V16, P297